← Evidence map

ReviewCurrent diabetes reviews2024

Journey of Teplizumab: A Promising Drug in the Treatment of Type 1 Diabetes Mellitus.

Nikita Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38279734